IL200202A0 - Novel proteins - Google Patents

Novel proteins

Info

Publication number
IL200202A0
IL200202A0 IL200202A IL20020209A IL200202A0 IL 200202 A0 IL200202 A0 IL 200202A0 IL 200202 A IL200202 A IL 200202A IL 20020209 A IL20020209 A IL 20020209A IL 200202 A0 IL200202 A0 IL 200202A0
Authority
IL
Israel
Prior art keywords
novel proteins
proteins
novel
Prior art date
Application number
IL200202A
Other languages
English (en)
Original Assignee
Orly Devary
Tamara Sandler
Two To Biotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orly Devary, Tamara Sandler, Two To Biotech Ltd filed Critical Orly Devary
Priority to IL200202A priority Critical patent/IL200202A0/en
Publication of IL200202A0 publication Critical patent/IL200202A0/en
Priority to AU2010280368A priority patent/AU2010280368B2/en
Priority to SG2012005070A priority patent/SG178097A1/en
Priority to PCT/IL2010/000621 priority patent/WO2011016026A2/en
Priority to IN879DEN2012 priority patent/IN2012DN00879A/en
Priority to EP15182357.2A priority patent/EP2985035A1/en
Priority to CA2769001A priority patent/CA2769001C/en
Priority to HK12112520.0A priority patent/HK1171672B/en
Priority to EP10806144.1A priority patent/EP2461829B1/en
Priority to CN201080044688.3A priority patent/CN102596247B/zh
Priority to US13/387,392 priority patent/US8647632B2/en
Priority to JP2012523432A priority patent/JP2013500739A/ja
Priority to KR1020127004449A priority patent/KR101623355B1/ko
Priority to SG10201404735VA priority patent/SG10201404735VA/en
Priority to IL217758A priority patent/IL217758A/en
Priority to US14/146,237 priority patent/US9296786B2/en
Priority to JP2015047903A priority patent/JP5833780B2/ja
Priority to IL240134A priority patent/IL240134A/en
Priority to JP2015155720A priority patent/JP2015212302A/ja
Priority to US14/953,759 priority patent/US20160083445A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
IL200202A 2009-08-02 2009-08-02 Novel proteins IL200202A0 (en)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IL200202A IL200202A0 (en) 2009-08-02 2009-08-02 Novel proteins
SG10201404735VA SG10201404735VA (en) 2009-08-02 2010-08-02 Novel proteins
EP10806144.1A EP2461829B1 (en) 2009-08-02 2010-08-02 Novel proteins
US13/387,392 US8647632B2 (en) 2009-08-02 2010-08-02 Proteins
PCT/IL2010/000621 WO2011016026A2 (en) 2009-08-02 2010-08-02 Novel proteins
IN879DEN2012 IN2012DN00879A (enExample) 2009-08-02 2010-08-02
EP15182357.2A EP2985035A1 (en) 2009-08-02 2010-08-02 Proteins
CA2769001A CA2769001C (en) 2009-08-02 2010-08-02 Chemokine-like secreted proteins involved in glucose metabolism
HK12112520.0A HK1171672B (en) 2009-08-02 2010-08-02 Novel proteins
AU2010280368A AU2010280368B2 (en) 2009-08-02 2010-08-02 Novel proteins
CN201080044688.3A CN102596247B (zh) 2009-08-02 2010-08-02 新蛋白
SG2012005070A SG178097A1 (en) 2009-08-02 2010-08-02 Novel proteins
JP2012523432A JP2013500739A (ja) 2009-08-02 2010-08-02 新規タンパク質
KR1020127004449A KR101623355B1 (ko) 2009-08-02 2010-08-02 신규 단백질
IL217758A IL217758A (en) 2009-08-02 2012-01-26 Polypeptides that increase glucose metabolism, their encoded nucleic acid molecules, their pharmaceutical preparations and their use in the preparation of drugs
US14/146,237 US9296786B2 (en) 2009-08-02 2014-01-02 Shortened secreted polypeptides
JP2015047903A JP5833780B2 (ja) 2009-08-02 2015-03-11 新規タンパク質
IL240134A IL240134A (en) 2009-08-02 2015-07-23 Polypeptides that Increase Testosterone Production, Nucleic Acid Molecules, and Pharmaceutical Preparations Containing Them
JP2015155720A JP2015212302A (ja) 2009-08-02 2015-08-06 新規タンパク質
US14/953,759 US20160083445A1 (en) 2009-08-02 2015-11-30 Novel polypeptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL200202A IL200202A0 (en) 2009-08-02 2009-08-02 Novel proteins

Publications (1)

Publication Number Publication Date
IL200202A0 true IL200202A0 (en) 2010-05-31

Family

ID=42263570

Family Applications (3)

Application Number Title Priority Date Filing Date
IL200202A IL200202A0 (en) 2009-08-02 2009-08-02 Novel proteins
IL217758A IL217758A (en) 2009-08-02 2012-01-26 Polypeptides that increase glucose metabolism, their encoded nucleic acid molecules, their pharmaceutical preparations and their use in the preparation of drugs
IL240134A IL240134A (en) 2009-08-02 2015-07-23 Polypeptides that Increase Testosterone Production, Nucleic Acid Molecules, and Pharmaceutical Preparations Containing Them

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL217758A IL217758A (en) 2009-08-02 2012-01-26 Polypeptides that increase glucose metabolism, their encoded nucleic acid molecules, their pharmaceutical preparations and their use in the preparation of drugs
IL240134A IL240134A (en) 2009-08-02 2015-07-23 Polypeptides that Increase Testosterone Production, Nucleic Acid Molecules, and Pharmaceutical Preparations Containing Them

Country Status (11)

Country Link
US (1) US8647632B2 (enExample)
EP (2) EP2461829B1 (enExample)
JP (3) JP2013500739A (enExample)
KR (1) KR101623355B1 (enExample)
CN (1) CN102596247B (enExample)
AU (1) AU2010280368B2 (enExample)
CA (1) CA2769001C (enExample)
IL (3) IL200202A0 (enExample)
IN (1) IN2012DN00879A (enExample)
SG (2) SG10201404735VA (enExample)
WO (1) WO2011016026A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2742061A4 (en) * 2011-08-08 2015-05-27 Two To Biotech Ltd NOVEL PEPTIDES, COMPOSITIONS COMPRISING THEM AND USES THEREOF IN METHODS FOR THE TREATMENT OF METABOLIC, CARDIAC AND IMMUNE DISORDERS
SG11201605354WA (en) * 2014-01-02 2016-07-28 Two To Biotech Ltd Novel polypeptides
CN104262468B (zh) * 2014-09-28 2017-01-18 新乡医学院 一种葡萄糖转运蛋白抑制多肽及其制备方法、应用
ES2746157T3 (es) 2015-03-05 2020-03-04 Sekisui Specialty Chemicals Am Dispersante de PVOH para polimerización de VCM
US11427872B2 (en) 2015-12-11 2022-08-30 National University Corporation Kochi University Marker for pancreatic cancer and intraductal papillary mucinous neoplasms

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5286846A (en) 1991-06-14 1994-02-15 The Government Of The United States Of America As Represented By The Dept. Of Health And Human Services Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
WO2001087316A2 (en) * 2000-05-15 2001-11-22 Braswell, Glenn, A. Composition and method for increasing testosterone levels
EP1296706B1 (en) * 2000-06-19 2006-02-22 The Uab Research Foundation Osteoclast secreted chemokine and uses thereof
AU2003900747A0 (en) * 2003-02-18 2003-03-06 Garvan Institute Of Medical Research Diagnosis and treatment of pancreatic cancer
US20080206231A1 (en) * 2004-10-05 2008-08-28 Oregon Health And Science University Compositions and Methods for Treating Disease
US20080248134A1 (en) * 2005-05-04 2008-10-09 Auckland Uniservices Limited Oral compositions, use and combinations of N-[2-(dimethylamino)ethyl]-2,6 dimethyl-1-oxo-1,2-dihydrobenzo[b]-1,6-naphthyridine-4-carboxamide and closely related analogues thereof
US20090018031A1 (en) * 2006-12-07 2009-01-15 Switchgear Genomics Transcriptional regulatory elements of biological pathways tools, and methods

Also Published As

Publication number Publication date
KR20120063474A (ko) 2012-06-15
HK1171672A1 (zh) 2013-04-05
CN102596247A (zh) 2012-07-18
AU2010280368A1 (en) 2012-03-15
JP2015157811A (ja) 2015-09-03
SG178097A1 (en) 2012-03-29
CA2769001A1 (en) 2011-02-10
KR101623355B1 (ko) 2016-05-23
IL240134A (en) 2016-07-31
IL217758A (en) 2015-10-29
US20120121602A1 (en) 2012-05-17
EP2461829A4 (en) 2013-06-19
US8647632B2 (en) 2014-02-11
IN2012DN00879A (enExample) 2015-07-10
CA2769001C (en) 2016-07-26
CN102596247B (zh) 2014-08-06
IL240134A0 (en) 2015-09-24
EP2461829A2 (en) 2012-06-13
JP2013500739A (ja) 2013-01-10
WO2011016026A3 (en) 2011-05-26
EP2985035A1 (en) 2016-02-17
WO2011016026A2 (en) 2011-02-10
SG10201404735VA (en) 2014-10-30
AU2010280368B2 (en) 2015-07-23
JP2015212302A (ja) 2015-11-26
IL217758A0 (en) 2012-03-29
JP5833780B2 (ja) 2015-12-16
EP2461829B1 (en) 2016-01-06

Similar Documents

Publication Publication Date Title
PL2406399T3 (pl) Białka mirac
IL214996A0 (en) Anti-bcma antibodies
GB0920127D0 (en) Antibodies
GB0909906D0 (en) Antibodies
IL213794A0 (en) Novel uses
PL2410869T3 (pl) Odzyskiwanie białka
GB0907413D0 (en) Novel methods
ZA201109437B (en) Novel azabicyclohexanes
EP2427496A4 (en) ANTI-VEGF-D ANTIBODIES
ZA201202266B (en) Insecticidal proteins
IL214232A0 (en) Novel tricyanoborates
GB0920324D0 (en) Antibodies
GB0904842D0 (en) Protein labelling
EP2480578A4 (en) MODIFICATION OF POLYPEPTIDE
IL240134A0 (en) new proteins
ZA201108446B (en) FViII-DERIVED PEPTIDES
EP2499256A4 (en) ANTI-C-MPL ANTIBODIES
ZA201109283B (en) Protein
ZA201203722B (en) Peptide
SG10201408577SA (en) Protein display
GB2483195B (en) Novel uses
GB0909502D0 (en) Novel protein crystallization technique
GB0907601D0 (en) Novel methods
GB0904677D0 (en) Novel case
GB0916844D0 (en) Novel case